Beijing Tiantan Biological Products Co., Ltd. (600161)
Market Closed
12 Dec, 06:57
SSE SSE Primary ¥
16. 34
-0.33
-1.98%
¥
39.21B Market Cap
30.5 P/E Ratio
0.6% Div Yield
25,583,830 Volume
0 Eps
¥ 16.67
Previous Close Day Range
16.28 16.7
Year Range
16.28 23.61
Want to track 600161 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
600161 closed Friday lower at ¥16.34, a decrease of 1.98% from Thursday's close, completing a monthly decrease of -1.98% or ¥0.33. Over the past 12 months, 600161 stock lost -20.49%.
600161 pays dividends to its shareholders, with the most recent payment made on Sep 25, 2025. The next estimated payment will be in In 1 weeks on Dec 25, 2025 for a total of ¥0.15.
The last earnings report, released on Oct 24, 2025, missed the consensus estimates by -0.06%. On average, the company has fell short of earnings expectations by -0.02%, based on the last three reports.
Beijing Tiantan Biological Products Co., Ltd. has completed 4 stock splits, with the recent split occurring on Jun 20, 2024.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on SSE (CNY).
600161 Chart
Similar
Beijing Tiantan Biological Products Co., Ltd. (600161) FAQ
What is the stock price today?
The current price is ¥16.34.
On which exchange is it traded?
Beijing Tiantan Biological Products Co., Ltd. is listed on SSE.
What is its stock symbol?
The ticker symbol is 600161.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.6%.
What is its market cap?
As of today, the market cap is 39.21B.
Has Beijing Tiantan Biological Products Co., Ltd. ever had a stock split?
Beijing Tiantan Biological Products Co., Ltd. had 4 splits and the recent split was on Jun 20, 2024.
Beijing Tiantan Biological Products Co., Ltd. Profile
| Biotechnology Industry | Healthcare Sector | Mr. Dao Xing Fu CEO | SSE Exchange | CNE000000WF9 ISIN |
| CN Country | 4,858 Employees | 25 Sep 2025 Last Dividend | 20 Jun 2024 Last Split | 18 May 1998 IPO Date |
Overview
Beijing Tiantan Biological Products Co., Ltd. is a prominent player in the biopharmaceutical industry, primarily focused on the research and development, manufacture, sale, and consulting of blood products. Founded in 1919 and with its headquarters established in Beijing, China, this company has carved a niche for itself in the Chinese biopharmaceutical sector. As a subsidiary of China National Biotec Group Company Limited, Beijing Tiantan Biological Products operates under a considerable banner, contributing significant advancements and innovations in the field of biotechnology and pharmaceuticals, with a strong emphasis on products derived from human blood.
Products and Services
The company's portfolio encompasses a diverse range of blood-related products, tailored to meet a variety of medical needs. Their product lineup includes:
- Human Albumin: A vital protein used in the treatment of shocks, burns, and low blood protein levels. It plays a crucial role in maintaining blood volume and pressure.
- Intravenous Human Immunoglobulin: A therapy used for a range of immune deficiencies and autoimmune and inflammatory diseases, providing essential antibodies to patients with deficient or malfunctioning immune systems.
- Tetanus Human Immunoglobulin: Specifically used for the prevention and treatment of tetanus, offering immediate immunity through the provision of tetanus antibodies.
- Rabies Patient Immunoglobulin: Used as post-exposure prophylaxis against rabies infections, providing immediate but temporary antibodies to fight the virus following exposure.
- Hepatitis B Human Immunoglobulin: Administered to prevent hepatitis B infection in individuals exposed to the virus, as well as in other specific medical situations like the newborns of mothers who are hepatitis B surface antigen positive.
- Freeze-dried Intravenous Hepatitis B Human Immunoglobulin: A specialized formulation of hepatitis B immunoglobulin, designed for intravenous administration, offering convenience and improved stability.
- Human Prothrombin Complex: This product is crucial for patients with clotting disorders, providing a concentrate of clotting factors to manage and prevent bleeding episodes.
Contact Information
Address: No.B2 Shuangqiao Road, Beijing, China, 100024
Phone: 86 10 6543 4018
Website: https://www.tiantanbio.com
2025 © Marketlog. All Rights Reserved.
